ProfileGDS4718 / 207282_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 59% 60% 53% 58% 55% 54% 54% 60% 63% 56% 54% 58% 57% 54% 55% 55% 57% 58% 55% 67% 57% 56% 56% 54% 56% 51% 55% 56% 62% 61% 58% 50% 59% 56% 54% 52% 55% 59% 57% 54% 55% 56% 52% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0808459
GSM549102patient 115, normal, homogenized [OPG study]6.1080660
GSM549104patient 119, normal, homogenized [OPG study]5.6558153
GSM549108patient 138, normal, homogenized [OPG study]6.044558
GSM549119patient 077, normal, homogenized [OPG study]5.8460455
GSM549133patient 032, cancer, homogenized [OPG study]5.6883754
GSM549139patient 042, cancer, homogenized [OPG study]5.7082454
GSM549099patient 107, normal, homogenized [OPG study]6.1290660
GSM549109patient 139, normal, homogenized [OPG study]6.3443263
GSM549110patient 046, normal, homogenized [OPG study]5.8652556
GSM549114patient 063, normal, homogenized [OPG study]5.7184554
GSM549122patient 082, normal, homogenized [OPG study]6.0098458
GSM549134patient 033, cancer, homogenized [OPG study]5.8963157
GSM549136patient 036, cancer, homogenized [OPG study]5.7047754
GSM549140patient 044, cancer, homogenized [OPG study]5.7648255
GSM549111patient 047, normal, homogenized [OPG study]5.7897255
GSM549113patient 057, normal, homogenized [OPG study]5.8850257
GSM549132patient 031, cancer, homogenized [OPG study]5.9548158
GSM549137patient 038, cancer, homogenized [OPG study]5.7753155
GSM549142patient 047, cancer, homogenized [OPG study]6.6439767
GSM549100patient 110, normal, homogenized [OPG study]5.9101457
GSM549107patient 135, normal, homogenized [OPG study]5.8238156
GSM549115patient 068, normal, homogenized [OPG study]5.8528856
GSM549116patient 072, normal, homogenized [OPG study]5.7436854
GSM549120patient 078, normal, homogenized [OPG study]5.8629856
GSM549131patient 030, cancer, homogenized [OPG study]5.5396851
GSM549118patient 074, normal, homogenized [OPG study]5.8195555
GSM549129patient 027, cancer, homogenized [OPG study]5.8631756
GSM549123patient 088, normal, homogenized [OPG study]6.2781962
GSM549124patient 006, cancer, homogenized [OPG study]6.1696761
GSM549126patient 015, cancer, homogenized [OPG study]5.9646658
GSM549128patient 025, cancer, homogenized [OPG study]5.5270650
GSM549103patient 117, normal, homogenized [OPG study]6.047259
GSM549117patient 073, normal, homogenized [OPG study]5.8338556
GSM549138patient 041, cancer, homogenized [OPG study]5.7410754
GSM549141patient 045, cancer, homogenized [OPG study]5.5952152
GSM549130patient 028, cancer, homogenized [OPG study]5.7833255
GSM549101patient 111, normal, homogenized [OPG study]6.0969659
GSM549105patient 128, normal, homogenized [OPG study]5.959757
GSM549106patient 134, normal, homogenized [OPG study]5.725954
GSM549112patient 048, normal, homogenized [OPG study]5.7835255
GSM549125patient 011, cancer, homogenized [OPG study]5.8586256
GSM549127patient 024, cancer, homogenized [OPG study]5.6407252
GSM549135patient 035, cancer, homogenized [OPG study]5.5589951